1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Obesity awareness as a medical condition Metastatic breast cancer awareness

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Financial Institutions/Investments/Securities FIN

Student Loan Auction Rate Securities

LobbyistCovered position, as disclosed
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Education EDU

Student Loan Auction Rate Securities

LobbyistCovered position, as disclosed
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

FDA-DEA controlled substances scheduling processes "Track and Trace" legislation

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Coverage and reimbursement issues Average Sales Price reduction for Medicare Part B products Repeal Medicare Part D coverage exclusion for obesity drugs

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.